Table 2.

Adjusted multinomial regression model, odds of follow-up care with a surgeon compared with a medical oncologist and odds of follow-up care with a PCP/other compared with medical oncologist

	Surgeon vs. Medical Oncologist Follow Up n=706		PCP/other vs. Medical Oncologist Follow Up n=784
	OR	95% CI	OR	95% CI
Age (years)	0.99	0.96–1.03	1.02	0.99–1.05
Race
White	1.00		1.00
Black	2.47	1.16–5.27	2.62	1.47–4.65
Latina	1.36	0.50–3.71	2.33	1.15–4.73
Insurance Coverage
Private/other	1.00		1.00
Medicare	2.47	0.88–6.96	1.28	0.64–2.56
Medicaid	0.94	0.19–4.65	2.52	1.24–5.15
No insurance	1.67	0.44–6.27	0.93	0.35–2.44
Education
Less than high school	1.00		1.00
High school graduate	0.98	0.33–2.92	0.79	0.39–1.62
Some college or more	1.04	0.41–2.59	0.72	0.38–1.34
Stage
I	1.00		1.00
II	0.97	0.46–2.02	1.03	0.55–1.94
III	0.56	0.20–1.62	0.83	0.34–2.05
Received Systemic Chemotherapy
Yes	1.00		1.00
No	1.58	0.61–4.10	1.14	0.53–2.43
Endocrine Therapy Use
Never	1.00		1.00
Past	0.54	0.21–1.36	0.67	0.35–1.26
Current	0.35	0.14–0.86	0.33	0.17–0.64

PCP: Primary Care Physician

Model adjusted for baseline consultation with medical oncologist before breast cancer surgery and geographic location. Model weighted for sample demographics and survey non-response.